SNRPD1 confers diagnostic and therapeutic values on breast cancers through cell cycle regulation.

Kostya Ken OstrikovLihui YuXiao ChenJianying Zhang

Published in: Cancer cell international (2021)

Our results suggested the prognostic value of SNRPD1 on breast cancer survival, its potential as the therapeutic target halting cell cycle progression for breast cancer control, and warranted special attention on the combined use of doxorubicin and drugs targeting SNRPD1.

Keyphrases

cell cycle
cell proliferation
cancer therapy
working memory
drug delivery
childhood cancer
young adults
free survival